Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
28054 | 176 | 32.6 | 71% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3426 | 1132 | LOBAPLATIN//AFFILIATED JIANGSU CANC HOSP//PHY906 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LOBAPLATIN | Author keyword | 25 | 70% | 12% | 21 |
2 | AFFILIATED JIANGSU CANC HOSP | Address | 20 | 46% | 18% | 32 |
3 | PHY906 | Author keyword | 9 | 83% | 3% | 5 |
4 | KANGLAITE INJECTION | Author keyword | 2 | 67% | 1% | 2 |
5 | CANTHARIDES SODIUM INJECTION | Author keyword | 1 | 100% | 1% | 2 |
6 | JAVANICA OIL EMULSION INJECTION | Author keyword | 1 | 100% | 1% | 2 |
7 | WOMEN HLTH CARE | Address | 1 | 33% | 1% | 2 |
8 | ANAL PRESERVING SURGERY | Author keyword | 1 | 50% | 1% | 1 |
9 | COMPLEMENTARY MED COMPLEMED | Address | 1 | 50% | 1% | 1 |
10 | CONTROLLED RELEASE DRUG | Address | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LOBAPLATIN | 25 | 70% | 12% | 21 | Search LOBAPLATIN | Search LOBAPLATIN |
2 | PHY906 | 9 | 83% | 3% | 5 | Search PHY906 | Search PHY906 |
3 | KANGLAITE INJECTION | 2 | 67% | 1% | 2 | Search KANGLAITE+INJECTION | Search KANGLAITE+INJECTION |
4 | CANTHARIDES SODIUM INJECTION | 1 | 100% | 1% | 2 | Search CANTHARIDES+SODIUM+INJECTION | Search CANTHARIDES+SODIUM+INJECTION |
5 | JAVANICA OIL EMULSION INJECTION | 1 | 100% | 1% | 2 | Search JAVANICA+OIL+EMULSION+INJECTION | Search JAVANICA+OIL+EMULSION+INJECTION |
6 | ANAL PRESERVING SURGERY | 1 | 50% | 1% | 1 | Search ANAL+PRESERVING+SURGERY | Search ANAL+PRESERVING+SURGERY |
7 | ENDOSTAR R | 1 | 50% | 1% | 1 | Search ENDOSTAR+R | Search ENDOSTAR+R |
8 | INOPERABLE ESOPHAGEAL CANCER | 1 | 50% | 1% | 1 | Search INOPERABLE+ESOPHAGEAL+CANCER | Search INOPERABLE+ESOPHAGEAL+CANCER |
9 | LIVER PRENEOLASTIC LESION | 1 | 50% | 1% | 1 | Search LIVER+PRENEOLASTIC+LESION | Search LIVER+PRENEOLASTIC+LESION |
10 | MUTY HOMOLOGUE | 1 | 50% | 1% | 1 | Search MUTY+HOMOLOGUE | Search MUTY+HOMOLOGUE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MATERIAL TAM | 73 | 96% | 13% | 23 |
2 | D 19466 | 13 | 71% | 6% | 10 |
3 | TREATING PATIENTS | 10 | 44% | 10% | 17 |
4 | POSTOPERATIVE ADJUVANT CHEMOTHERAPY | 9 | 21% | 23% | 40 |
5 | JIEDU XIAOZHENG YIN | 1 | 50% | 1% | 2 |
6 | METASTATIC GASTRIC CANCER | 1 | 25% | 2% | 4 |
7 | PHY906 | 1 | 40% | 1% | 2 |
8 | HUQI SAN | 1 | 50% | 1% | 1 |
9 | ADJUVANT REGIONAL CHEMOTHERAPY | 0 | 33% | 1% | 1 |
10 | HODGKINS LYMPHOMA INCIDENCE | 0 | 33% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Traditional Chinese Medicine in Cancer Care: A Review of Case Series Published in the Chinese Literature | 2012 | 8 | 1 | 100% |
Old formula, new Rx: The journey of PHY906 as cancer adjuvant therapy | 2012 | 22 | 26 | 19% |
Traditional Herbal Medicine: A Review of Potential of Inhibitory Hepatocellular Carcinoma in Basic Research and Clinical Trial | 2013 | 3 | 28 | 21% |
Adaption and Application of the Four Phase Trials to Traditional Chinese Medicines | 2013 | 0 | 21 | 14% |
The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer | 2015 | 0 | 70 | 13% |
Herbal medicines for advanced colorectal cancer | 2012 | 0 | 18 | 6% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AFFILIATED JIANGSU CANC HOSP | 20 | 46% | 18% | 32 |
2 | WOMEN HLTH CARE | 1 | 33% | 1.1% | 2 |
3 | COMPLEMENTARY MED COMPLEMED | 1 | 50% | 0.6% | 1 |
4 | CONTROLLED RELEASE DRUG | 1 | 50% | 0.6% | 1 |
5 | DEV THER EUT PROGRAMYALE CANC | 1 | 50% | 0.6% | 1 |
6 | HONG KONG COCHRANE | 1 | 50% | 0.6% | 1 |
7 | MINIST PUBL HLTH LIVING DONOR LIVER TRANS | 1 | 50% | 0.6% | 1 |
8 | SUBEI PEOPLE HOSP JIANGSU PROV | 1 | 50% | 0.6% | 1 |
9 | SURVEILLANCE INFORMAT | 1 | 50% | 0.6% | 1 |
10 | TRADIT CHINESE MED TRAUMATOL | 1 | 50% | 0.6% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000113643 | 2 3 4 DIARYL 5 OXO 1 2 4 TRIAZINE 6 YLIDENEACETATES//3 4 DIARYL 1 2 4 TRIAZOLO 5 CARBOXYLATES//ADEUOVIRUS |
2 | 0.0000092043 | CALVERT FORMULA//CHATELUT FORMULA//SKI 2053R |
3 | 0.0000085393 | ASIAN CANCER CONTROL//BUR HLTH TECHNOL RD PLANNING BUDGET MANAGEMENT//EARLY DETECT PREVENT |
4 | 0.0000066845 | ECRG4//ECRG2//ECRG1 |
5 | 0.0000062467 | PEMETREXED//MULTITARGETED ANTIFOLATE//NONSQUAMOUS |
6 | 0.0000055771 | PIEN TZE HUANG//BOFUTSUSHOSAN//POSTDOCTOR WORKSTN |
7 | 0.0000053408 | PBK TOPK//PDZ BINDING KINASE//PBK |
8 | 0.0000047271 | NORCANTHARIDIN//CANTHARIDIN//PYROCHROIDAE |
9 | 0.0000043429 | BUFALIN//CINOBUFAGIN//BUFADIENOLIDES |
10 | 0.0000042838 | PLATINUM BASED DRUG//JM216//PLATINUM COMPLEXES |